 | Up a level |
2022
Aoki, Shuichi, Inoue, Koetsu, Klein, Sebastian 
ORCID: 0000-0002-2188-9377, Halvorsen, Stefan, Chen, Jiang, Matsui, Aya, Nikmaneshi, Mohammad R., Kitahara, Shuji ORCID: 0000-0002-2904-0319, Hato, Tai ORCID: 0000-0002-1319-505X, Chen, Xianfeng ORCID: 0000-0002-7531-5862, Kawakubo, Kazumichi ORCID: 0000-0002-8979-9474, Nia, Hadi T., Chen, Ivy, Schanne, Daniel H., Mamessier, Emilie ORCID: 0000-0002-3516-0093, Shigeta, Kohei ORCID: 0000-0003-1596-4200, Kikuchi, Hiroto, Ramjiawan, Rakesh R., Schmidt, Tyge C. E., Iwasaki, Masaaki, Yau, Thomas, Hong, Theodore S., Quaas, Alexander, Plum, Patrick S. ORCID: 0000-0002-8165-4553, Dima, Simona, Popescu, Irinel, Bardeesy, Nabeel, Munn, Lance L., Borad, Mitesh J., Sassi, Slim, Jain, Rakesh K., Zhu, Andrew X. and Duda, Dan G.
(2022).
Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma.
Gut, 71 (1).
S. 185 - 194.
LONDON:
BMJ PUBLISHING GROUP.
ISSN 1468-3288
2021
Javle, Milind, Roychowdhury, Sameek, Kelley, Robin Kate, Sadeghi, Saeed, Macarulla, Teresa ORCID: 0000-0002-5856-4082, Weiss, Karl Heinz, Waldschmidt, Dirk-Thomas, Goyal, Lipika, Borbath, Ivan, El-Khoueiry, Anthony, Borad, Mitesh J., Yong, Wei Peng, Philip, Philip A., Bitzer, Michael, Tanasanvimon, Surbpong, Li, Ai, Pande, Amit, Soifer, Harris S., Shepherd, Stacie Peacock, Moran, Susan, Zhu, Andrew X., Bekaii-Saab, Tanios S. and Abou-Alfa, Ghassan K.
(2021).
Infigratinib (BGJ398) in previously treated patients with advanced or metastatic cholangiocarcinoma with FGFR2 fusions or rearrangements: mature results from a multicentre, open-label, single-arm, phase 2 study.
Lancet Gastroenterol. Hepatol., 6 (10).
S. 803 - 816.
SAN DIEGO:
ELSEVIER INC.
ISSN 2468-1253
2020
Makawita, Shalini, Kelley, Robin Kate, Roychowdhury, Sameek, Weiss, Karl Heinz, Abou-Alfa, Ghassan K., Macarulla, Teresa, Sadeghi, Saeed, Waldschmidt, Dirk, Zhu, Andrew X., Goyal, Lipika, Yong, Wei-Peng, Borbath, Ivan, El-Khoueiry, Anthony B., Philip, Philip Agop, Moran, Susan, Ye, Yining, Soifer, Harris S., Li, Gary, Berman, Craig and Javle, Milind M. (2020). Circulating free DNA (cfDNA) and tissue next-generation sequencing analysis in a phase II study of infigratinib (BGJ398) for cholangiocarcinoma with FGFR2 fusions. J. Clin. Oncol., 38 (4). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Shigeta, Kohei, Matsui, Aya, Kikuchi, Hiroto, Klein, Sebastian ORCID: 0000-0002-2188-9377, Mamessier, Emilie, Chen, Ivy X., Aoki, Shuichi, Kitahara, Shuji ORCID: 0000-0002-2904-0319, Inoue, Koetsu, Shigeta, Ayako, Hato, Tai, Ramjiawan, Rakesh R., Staiculescu, Daniel, Zopf, Dieter, Fiebig, Lukas, Hobbs, Gabriela S., Quaas, Alexander, Dima, Simona, Popescu, Irinel, Huang, Peigen, Munn, Lance L., Cobbold, Mark, Goyal, Lipika, Zhu, Andrew X., Jain, Rakesh K. and Duda, Dan G.
(2020).
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma.
J. Immunother. Cancer, 8 (2).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2051-1426